跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LETYBO (letibotulinumtoxinA) 50 U Powder for injection - TGA Drug Approval Details
Approvals
/
TGA
/
LETYBO (letibotulinumtoxinA) 50 U Powder for injection
Approved
STANDARD
LETYBO (letibotulinumtoxinA) 50 U Powder for injection
Hugel Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
13373aa744340b7d
Company
Hugel Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
13373aa744340b7d
Product Name
LETYBO (letibotulinumtoxinA) 50 U Powder for injection
Artg Id
370012
Artg Name
LETYBO (letibotulinumtoxinA) 50 U, Powder for injection
Sponsor
Hugel Australia Pty Ltd
Company Detail Path
/organization/hugel-australia-pty-ltd
Artg Date
2022-11-28
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/8e4d75ee4bcbc443771b628e2384eed3.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/dcfcdd592276d0fe23e6e03b2460a0b8.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
13373aa744340b7d
Type
Standard
Back to TGA Approvals